New transcatheter valve safe, effective for treating aortic regurgitation
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...
Five-year outcomes similar for low-risk patients receiving transcatheter, surgical aortic valve replacement
Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...
MassDevice11h
JenaValve data backs TAVR system for treating aortic regurgitation
JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.
MassDevice11h
MiRus kicks off Siegel heart valve early feasibility study
MiRus announced that it launched a U.S. multi-center early feasibility study for its Siegel transcatheter heart valve (THV).
American Hospital Association7h
FDA recalls Medtronic Aortic Root Cannulas
The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of ...
News-Medical.Net on MSN16h
Embolic protection device does not reduce stroke rate in TAVR procedure
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...